Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin R Pritchard

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Plos Computational Biology|October 29, 2019
Evolution of the nonsense-mediated decay pathway is associated with decreased cytolytic immune infiltrationBoyang Zhao, Justin R Pritchard
Plos Genetics|June 16, 2016
Inherited Disease Genetics Improves the Identification of Cancer-Associated GenesBoyang Zhao, Justin R Pritchard
Msystems|August 17, 2021
Refined Quantification of Infection Bottlenecks and Pathogen Dissemination with STAMPRKarthik Hullahalli, Justin R Pritchard, Matthew K Waldor
PNAS Nexus|September 25, 2025
Efficient mathematical methodology to determine multistep mutant burden in spatially growing cell populationsNatalia L Komarova, Justin R Pritchard, Dominik Wodarz
Soft Matter|April 21, 2022
Materials-driven approaches to understand extrinsic drug resistance in cancerJustin R Pritchard, Michael J Lee, Shelly R Peyton
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 21, 2012
Understanding resistance to combination chemotherapyJustin R Pritchard, Douglas A Lauffenburger, Michael T Hemann
Haematologica|February 5, 2026
Interleukin signaling mitigates the inhibitory effects of combined Src/BCR-ABL1 blockade on T-cell activity in Philadelphia chromosome-positive acute lymphoblastic leukemiaFarnaz Naeemikia, Joshua Reynolds, Cheng Dong, et al.
Cancer Discovery|December 10, 2013
Addressing genetic tumor heterogeneity through computationally predictive combination therapyBoyang Zhao, Justin R Pritchard, Douglas A Lauffenburger, et al.
Molecular Biosystems|January 5, 2013
Predicting cancer drug mechanisms of action using molecular network signaturesJustin R Pritchard, Peter M Bruno, Michael T Hemann, et al.
BMC Genomics|June 3, 2014
Disruption of Mycobacterium avium subsp. paratuberculosis-specific genes impairs in vivo fitnessJoyce Wang, Justin R Pritchard, Louis Kreitmann, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Plos Computational Biology|October 29, 2019
Evolution of the nonsense-mediated decay pathway is associated with decreased cytolytic immune infiltrationBoyang Zhao, Justin R Pritchard
Plos Genetics|June 16, 2016
Inherited Disease Genetics Improves the Identification of Cancer-Associated GenesBoyang Zhao, Justin R Pritchard
Msystems|August 17, 2021
Refined Quantification of Infection Bottlenecks and Pathogen Dissemination with STAMPRKarthik Hullahalli, Justin R Pritchard, Matthew K Waldor
PNAS Nexus|September 25, 2025
Efficient mathematical methodology to determine multistep mutant burden in spatially growing cell populationsNatalia L Komarova, Justin R Pritchard, Dominik Wodarz
Soft Matter|April 21, 2022
Materials-driven approaches to understand extrinsic drug resistance in cancerJustin R Pritchard, Michael J Lee, Shelly R Peyton
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 21, 2012
Understanding resistance to combination chemotherapyJustin R Pritchard, Douglas A Lauffenburger, Michael T Hemann
Haematologica|February 5, 2026
Interleukin signaling mitigates the inhibitory effects of combined Src/BCR-ABL1 blockade on T-cell activity in Philadelphia chromosome-positive acute lymphoblastic leukemiaFarnaz Naeemikia, Joshua Reynolds, Cheng Dong, et al.
Cancer Discovery|December 10, 2013
Addressing genetic tumor heterogeneity through computationally predictive combination therapyBoyang Zhao, Justin R Pritchard, Douglas A Lauffenburger, et al.
Molecular Biosystems|January 5, 2013
Predicting cancer drug mechanisms of action using molecular network signaturesJustin R Pritchard, Peter M Bruno, Michael T Hemann, et al.
BMC Genomics|June 3, 2014
Disruption of Mycobacterium avium subsp. paratuberculosis-specific genes impairs in vivo fitnessJoyce Wang, Justin R Pritchard, Louis Kreitmann, et al.
Pageof 5